The Indiana University telephone-based assessment of neuropsychological status: a new method for large scale neuropsychological assessment.

PubWeight™: 1.16‹?› | Rank: Top 10%

🔗 View Article (PMC 2747375)

Published in J Int Neuropsychol Soc on September 01, 2007

Authors

Frederick W Unverzagt1, Patrick O Monahan, Lyndsi R Moser, Qianqian Zhao, Janet S Carpenter, George W Sledge, Victoria L Champion

Author Affiliations

1: Department of Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA. funverza@iupui.edu

Articles citing this

Trajectory of Cognitive Decline After Incident Stroke. JAMA (2015) 1.75

Depression among older adults in the United States and England. Am J Geriatr Psychiatry (2010) 1.48

Telephone assessment of cognitive function in the late-onset Alzheimer's disease family study. Arch Neurol (2010) 1.22

Relationship between depression, fatigue, subjective cognitive impairment, and objective neuropsychological functioning in patients with multiple sclerosis. Neuropsychology (2010) 1.02

Alterations in brain structure and function in breast cancer survivors: effect of post-chemotherapy interval and relation to oxidative DNA damage. Breast Cancer Res Treat (2012) 0.97

Evaluating cognition in an elderly cohort via telephone assessment. Int J Geriatr Psychiatry (2010) 0.87

Age differences in the association of obstructive sleep apnea risk with cognition and quality of life. J Sleep Res (2013) 0.82

Cognitive function in breast cancer survivors compared to healthy age- and education-matched women. Clin Neuropsychol (2009) 0.81

Performance of the NINDS-CSN 5-minute protocol in a national population-based sample. J Int Neuropsychol Soc (2014) 0.80

Lead exposure and rate of change in cognitive function in older women. Environ Res (2014) 0.80

Administration of neuropsychological tests using interactive voice response technology in the elderly: validation and limitations. Front Neurol (2013) 0.79

Correlates of Incident Cognitive Impairment in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Clin Neuropsychol (2015) 0.77

Can smartphones enhance telephone-based cognitive assessment (TBCA)? Int J Environ Res Public Health (2013) 0.76

Cognitive function in adults aging with fabry disease: a case-control feasibility study using telephone-based assessments. JIMD Rep (2015) 0.75

Articles cited by this

The measurement of observer agreement for categorical data. Biometrics (1977) 216.56

The mini-mental state examination: a comprehensive review. J Am Geriatr Soc (1992) 15.32

Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst (1998) 3.67

The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer (2004) 3.50

Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol (2002) 3.13

Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol (2000) 2.34

A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. Clin Neuropsychol (2006) 1.79

Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol (2003) 1.63

Collecting data on alcohol use and alcohol-related victimization: a comparison of telephone and Web-based survey methods. J Stud Alcohol (2006) 1.56

Late effects of adjuvant chemotherapy and postoperative radiotherapy on quality of life among breast cancer patients. Eur J Cancer (1991) 1.56

Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective. Breast Cancer Res Treat (2006) 1.11

Test-retest reliability of a new form of the auditory verbal learning test (AVLT). Arch Clin Neuropsychol (1994) 1.09

Self-ratings of memory dysfunction: different findings in depression and amnesia. J Clin Exp Neuropsychol (1988) 1.06

Measurement of antepartum depressive symptoms during high-risk pregnancy. Res Nurs Health (2005) 1.05

Alternate forms of the Auditory-Verbal Learning Test: issues of test comparability, longitudinal reliability, and moderating demographic variables. Arch Clin Neuropsychol (1995) 1.00

The reliability of cluster and switch scores for the Controlled Oral Word Association Test. Arch Clin Neuropsychol (2003) 0.89

Articles by these authors

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial. Lancet Oncol (2009) 9.39

Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med (2007) 9.05

Weekly paclitaxel in the adjuvant treatment of breast cancer. N Engl J Med (2008) 6.54

Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199. J Clin Oncol (2014) 5.61

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer. N Engl J Med (2015) 5.57

Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100. J Clin Oncol (2008) 5.38

Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory. J Clin Oncol (2008) 5.10

Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features. J Clin Oncol (2008) 4.42

Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial. J Clin Oncol (2008) 4.24

Efficacy and safety of lapatinib as first-line therapy for ErbB2-amplified locally advanced or metastatic breast cancer. J Clin Oncol (2008) 3.83

Derivation and Validation of a Scoring System to Stratify Risk for Advanced Colorectal Neoplasia in Asymptomatic Adults: A Cross-sectional Study. Ann Intern Med (2015) 3.45

Triple-negative breast cancer: risk factors to potential targets. Clin Cancer Res (2008) 3.25

Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27--a randomized controlled phase III trial. J Clin Oncol (2013) 3.24

Heterogeneity and cancer. Oncology (Williston Park) (2014) 2.89

Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial. JAMA (2011) 2.70

A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast. J Natl Cancer Inst (2013) 2.56

HER2 and chromosome 17 effect on patient outcome in the N9831 adjuvant trastuzumab trial. J Clin Oncol (2010) 2.49

A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer. Semin Oncol (2003) 2.23

Impact of PTEN protein expression on benefit from adjuvant trastuzumab in early-stage human epidermal growth factor receptor 2-positive breast cancer in the North Central Cancer Treatment Group N9831 trial. J Clin Oncol (2013) 2.15

A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale. J Clin Epidemiol (2004) 2.14

Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles. Clin Chem (2008) 1.96

Neuropathy is not associated with clinical outcomes in patients receiving adjuvant taxane-containing therapy for operable breast cancer. J Clin Oncol (2012) 1.85

Improvement in blood pressure with inhibition of the epithelial sodium channel in blacks with hypertension. Hypertension (2005) 1.85

Endoxifen, a secondary metabolite of tamoxifen, and 4-OH-tamoxifen induce similar changes in global gene expression patterns in MCF-7 breast cancer cells. J Pharmacol Exp Ther (2006) 1.84

p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy. J Natl Cancer Inst (2006) 1.74

Optimization of RNA extraction from FFPE tissues for expression profiling in the DASL assay. Biotechniques (2008) 1.72

Efficacy of exercise for menopausal symptoms: a randomized controlled trial. Menopause (2014) 1.67

Accuracy of subjective hot flush reports compared with continuous sternal skin conductance monitoring. Obstet Gynecol (2004) 1.59

Poly(ADP-Ribose) polymerase inhibition: "targeted" therapy for triple-negative breast cancer. Clin Cancer Res (2010) 1.56

Cognitive development in children with new onset epilepsy. Dev Med Child Neurol (2014) 1.55

Can tumor angiogenesis be inhibited without resistance? EXS (2005) 1.55

Is sternal skin conductance monitoring a valid measure of hot flash intensity or distress? Menopause (2005) 1.54

Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer. Oncologist (2007) 1.54

Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer. Cancer (2012) 1.52

Barriers to recruiting urban African American women into research studies in community settings. Appl Nurs Res (2008) 1.49

Effects of escitalopram on menopause-specific quality of life and pain in healthy menopausal women with hot flashes: a randomized controlled trial. Maturitas (2012) 1.49

The effects of oncotype DX recurrence scores on chemotherapy utilization in a multi-institutional breast cancer cohort. Breast Cancer Res Treat (2011) 1.46

Relapse of vasomotor symptoms after discontinuation of the selective serotonin reuptake inhibitor escitalopram: results from the menopause strategies: finding lasting answers for symptoms and health research network. Menopause (2013) 1.45

Efficacy of omega-3 for vasomotor symptoms treatment: a randomized controlled trial. Menopause (2014) 1.44

Efficacy of yoga for vasomotor symptoms: a randomized controlled trial. Menopause (2014) 1.44

Making personalized cancer medicine a reality: challenges and opportunities in the development of biomarkers and companion diagnostics. Clin Cancer Res (2012) 1.44

Sleep wake disturbances in people with cancer and their caregivers: state of the science. Oncol Nurs Forum (2005) 1.43

Rethinking the metastatic cascade as a therapeutic target. Nat Rev Clin Oncol (2011) 1.41

Twenty years of systemic therapy for breast cancer. Oncology (Williston Park) (2006) 1.41

Association of polymorphisms of angiogenesis genes with breast cancer. Breast Cancer Res Treat (2007) 1.41

Effects of estrogen and venlafaxine on menopause-related quality of life in healthy postmenopausal women with hot flashes: a placebo-controlled randomized trial. Menopause (2015) 1.40

Effect of memory impairment on training outcomes in ACTIVE. J Int Neuropsychol Soc (2007) 1.40

A randomized trial of two print interventions to increase colon cancer screening among first-degree relatives. Patient Educ Couns (2008) 1.36

Reproductive and sexual function after platinum-based chemotherapy in long-term ovarian germ cell tumor survivors: a Gynecologic Oncology Group Study. J Clin Oncol (2007) 1.36

A phase I-II study of combined blockade of the ErbB receptor network with trastuzumab and gefitinib in patients with HER2 (ErbB2)-overexpressing metastatic breast cancer. Clin Cancer Res (2008) 1.35

Comparison of younger and older breast cancer survivors and age-matched controls on specific and overall quality of life domains. Cancer (2014) 1.35

Phase I safety, pharmacokinetic and pharmacodynamic studies of 2-methoxyestradiol alone or in combination with docetaxel in patients with locally recurrent or metastatic breast cancer. Invest New Drugs (2006) 1.31

A cost-effectiveness comparison of three tailored interventions to increase mammography screening. J Womens Health (Larchmt) (2004) 1.31

Methods for the design of vasomotor symptom trials: the menopausal strategies: finding lasting answers to symptoms and health network. Menopause (2014) 1.31

A family study of pathological gambling. Psychiatry Res (2006) 1.26

Comparison of three interventions to increase mammography screening in low income African American women. Cancer Detect Prev (2006) 1.25

Comparison of subjective and objective hot flash measures over time among breast cancer survivors initiating aromatase inhibitor therapy. Menopause (2009) 1.24

An alternative to Unibase/glycol as an effective nonhydrating electrolyte medium for the measurement of electrodermal activity. Psychophysiology (2002) 1.23

Effects of HIV protease inhibitor ritonavir on Akt-regulated cell proliferation in breast cancer. Clin Cancer Res (2006) 1.23

Impact of the Cancer Risk Intake System on patient-clinician discussions of tamoxifen, genetic counseling, and colonoscopy. J Gen Intern Med (2005) 1.22

Somatic symptoms in patients with cancer experiencing pain or depression: prevalence, disability, and health care use. Arch Intern Med (2010) 1.22

Understanding diabetes medications from the perspective of patients with type 2 diabetes: prerequisite to medication concordance. Diabetes Educ (2006) 1.21

C-MYC alterations and association with patient outcome in early-stage HER2-positive breast cancer from the north central cancer treatment group N9831 adjuvant trastuzumab trial. J Clin Oncol (2011) 1.21

Intraclass correlation estimates for cancer screening outcomes: estimates and applications in the design of group-randomized cancer screening studies. J Natl Cancer Inst Monogr (2010) 1.20

Beliefs associated with fecal occult blood test and colonoscopy use at a worksite colon cancer screening program. J Occup Environ Med (2003) 1.20

Drug insight: VEGF as a therapeutic target for breast cancer. Nat Clin Pract Oncol (2007) 1.17

A cognitive behavioral intervention for symptom management in patients with advanced cancer. Oncol Nurs Forum (2005) 1.17

Assessment of differential item functioning for demographic comparisons in the MOS SF-36 health survey. Qual Life Res (2006) 1.16

What is targeted therapy? J Clin Oncol (2005) 1.16

Total pancreatectomy (R0 resection) improves survival over subtotal pancreatectomy in isolated neck margin positive pancreatic adenocarcinoma. Surgery (2007) 1.16

Telomerase template antagonist GRN163L disrupts telomere maintenance, tumor growth, and metastasis of breast cancer. Clin Cancer Res (2006) 1.16

Cancer patients' attitudes toward future research uses of stored human biological materials. J Empir Res Hum Res Ethics (2007) 1.15

Sociocultural context of mammography screening use. Oncol Nurs Forum (2006) 1.14

Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial. J Natl Cancer Inst (2012) 1.13

Systematic review of health-related quality of life models. Health Qual Life Outcomes (2012) 1.13

Promoting colorectal cancer screening discussion: a randomized controlled trial. Am J Prev Med (2013) 1.13

The association of depression and pain with health-related quality of life, disability, and health care use in cancer patients. J Pain Symptom Manage (2010) 1.12

The cost effectiveness of 5 interventions to increase mammography adherence in a managed care population. Am J Manag Care (2003) 1.11

Prevalence, severity, and correlates of sleep-wake disturbances in long-term breast cancer survivors. J Pain Symptom Manage (2010) 1.10

Randomized trial of a lay health advisor and computer intervention to increase mammography screening in African American women. Cancer Epidemiol Biomarkers Prev (2010) 1.09

An analysis of farmers' perception of the new cooperative medical system in Liaoning Province, China. BMC Health Serv Res (2009) 1.08

Predicting response to primary chemotherapy: gene expression profiling of paraffin-embedded core biopsy tissue. Breast Cancer Res Treat (2006) 1.08

Alteration of gene expression by alcohol exposure at early neurulation. BMC Genomics (2011) 1.08

Investigational drug MLN0128, a novel TORC1/2 inhibitor, demonstrates potent oral antitumor activity in human breast cancer xenograft models. Breast Cancer Res Treat (2012) 1.07

Impact of perceived cognitive impairment in breast cancer survivors. Eur J Oncol Nurs (2012) 1.07

Computer-delivered tailored intervention improves colon cancer screening knowledge and health beliefs of African-Americans. Health Educ Res (2012) 1.06

Persistent upregulation of U6:SNORD44 small RNA ratio in the serum of breast cancer patients. Breast Cancer Res (2011) 1.05

Design and methods of a multi-site, multi-behavioral treatment trial for menopausal symptoms: the MsFLASH experience. Contemp Clin Trials (2013) 1.05

Wnt signaling in triple negative breast cancer is associated with metastasis. BMC Cancer (2013) 1.05

The Indiana Cancer Pain and Depression (INCPAD) trial Design of a telecare management intervention for cancer-related symptoms and baseline characteristics of study participants. Gen Hosp Psychiatry (2009) 1.04

Analysis of angiogenesis genes from paraffin-embedded breast tumor and lymph nodes. Breast Cancer Res Treat (2006) 1.04

Extracellular proteolysis and cancer: meeting summary and future directions. Cancer Res (2003) 1.02